PREP-ing for Future Pandemics and AMR
As the Covid-19 pandemic rages, worries about rising antimicrobial resistance are increasing too. One company…
As the Covid-19 pandemic rages, worries about rising antimicrobial resistance are increasing too. One company…
The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial,…
A global collaboration including the pharmaceutical industry and public funders such as the European Investment…
Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective…
Researchers from the University of Southampton in the UK have used laser technology to create…
Ingestible pellets containing a charcoal-like treatment -- designed by the French company Da Volterra --…
Ares Genetics will use next-generation sequencing technology from the Chinese genomics company BGI Group to…
Mutabilis has received a €5M investment from the Danish VC Novo Holdings’ REPAIR Impact Fund…
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
An antibiotic candidate developed by the Irish company Iterum Therapeutics has failed to meet the…
Amidst recent listeria outbreaks in Europe, the European Court of Justice has issued a court…
The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day…